GL1X · GenesisL1 explorer

Research workbench

Crystal structure of human adenovirus 2 protease with a weak pyrimidine nitrile inhibitor

Analyse Crystal structure of human adenovirus 2 protease with a weak pyrimidine nitrile… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
4PID
Type
protein
Length
215 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protease; Pre-protein VI
EC
3.4.22.39
UniProt
P03252, P03274
Ligands
2UQ
Pockets
1 · best druggability 0.31

Structure

x-ray diffraction · 2 distinct chains · 40% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtease (EC 3.4.22.39)protein20442% helix, 16% strandP03252
BPre-protein VIprotein110% helix, 64% strandP03274

Ligands and binding sites

  • 2UQ · N-benzyl-2-[(Z)-iminomethyl]pyrimidine-5-carboxamide · ligand · chains A
  • ACT · Acetate ion · additive · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1620.310.75212UQ

Interfaces

1 interface between chains.

  • A–B · 888 Ų buried · 26 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 1 covalent, 1 disulfide (covalent ligand, disulfide).

Compared structures

  • 4PID · Crystal structure of human adenovirus 2 protease with a weak pyrimidine nitrile inhibitor · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.